Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate CancerWithdrawn
NCT01087580Phase 2Updated Mar 3, 2017
Sponsor: Northwestern University
PROSTATE CANCER
United States
OPTIMOX-aflibercept as First-line Therapy in Patients With Unresectable Metastatic Colorectal CancerCompleted
NCT01802684Phase 2Updated Mar 1, 2017
Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group
Unresectable Metastatic Colorectal Cancer
France
Title XELOX FOR SALIVARY GLAND CANCERSTerminated
NCT00101075Phase 2Updated Feb 27, 2017
Sponsor: Dana-Farber Cancer Institute
Head and Neck Cancer
United States
Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT)Unknown
NCT03057470Phase 4Updated Feb 20, 2017
Sponsor: LMC Diabetes & Endocrinology Ltd.
Diabetes Mellitus, Type 1
Canada
A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher PatientsCompleted
NCT00358150Phase 2Updated Feb 15, 2017
Sponsor: Genzyme, a Sanofi Company
Gaucher Disease, Type 1 · Cerebroside Lipidosis Syndrome · Glucocerebrosidase Deficiency Disease · Glucosylceramide Beta-Glucosidase Deficiency Disease
United States, Argentina, Israel, Italy, Mexico +1 more
Use of Alfuzosin in Stone Treatment With ESWLWithdrawn
NCT00388271Phase 3Updated Feb 10, 2017
Sponsor: Singapore General Hospital
Urinary Calculi
Singapore
A Study of the Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat TartrateCompleted
NCT02536911Phase 1Updated Feb 10, 2017
Sponsor: Genzyme, a Sanofi Company
Gaucher Disease
United States
Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic PatientsCompleted
NCT01476475Phase 2Updated Feb 10, 2017
Sponsor: Sanofi
Type 2 Diabetes Mellitus
United States, Chile, Czechia, Denmark, France +8 more
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal CancerCompleted
NCT01749956Phase 2Updated Feb 7, 2017
Sponsor: SCRI Development Innovations, LLC
Rectal Cancer
United States
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder CancerCompleted
NCT00361231Phase 2Updated Feb 7, 2017
Sponsor: Massachusetts General Hospital
Biliary Tract Cancer · Gallbladder Adenocarcinoma
United States
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)Completed
NCT01074944Phase 3Updated Feb 6, 2017
Sponsor: Genzyme, a Sanofi Company
Gaucher Disease
United States, Australia, Austria, Brazil, Canada +12 more
Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck CancerTerminated
NCT00256295Phase 2Updated Feb 1, 2017
Sponsor: Sai-Hong Ignatius Ou
Cancer of the Head and Neck
United States
Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer PatientsTerminated
NCT00879619Phase 1, Phase 2Updated Feb 1, 2017
Sponsor: John P. Fruehauf
Prostate Cancer · Adenocarcinoma of the Prostate · Recurrent Prostate Cancer · Stage I Prostate Cancer
United States
A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid CancerCompleted
NCT00358956Phase 2Updated Jan 30, 2017
Sponsor: Genzyme, a Sanofi Company
Thyroid Cancer
United States, Australia, Canada, Italy, Netherlands +3 more
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple SclerosisCompleted
NCT00803049Phase 3Updated Jan 30, 2017
Sponsor: Sanofi
Multiple Sclerosis
United States, Austria, Canada, Chile, Czechia +16 more
Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic PatientsTerminated
NCT02274740Phase 2Updated Jan 30, 2017
Sponsor: Sanofi
Type II Diabetes Mellitus
Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal CancerWithdrawn
NCT02046538Phase 2Updated Jan 25, 2017
Sponsor: Weill Medical College of Cornell University
Adenocarcinoma of the Colon · Adenocarcinoma of the Rectum
United States
A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive AdultsCompleted
NCT02420444Phase 1Updated Jan 24, 2017
Sponsor: Aeras
Tuberculosis
Switzerland
Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate CancerCompleted
NCT02441894Phase 4Updated Jan 24, 2017
Sponsor: Sanofi
Prostate Cancer
Japan
Thrombolysis Versus Primary Angioplasty for AMI in Elderly PatientsTerminated
NCT00257309Phase 4Updated Jan 19, 2017
Sponsor: Spanish Society of Cardiology
Acute Myocardial Infarction
Spain
Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes MellitusCompleted
NCT00315133Phase 1, Phase 2Updated Jan 18, 2017
Sponsor: University of Sao Paulo
Type 1 Diabetes Mellitus
Brazil
Establishment of Biomarkers for Fabry DiseaseCompleted
NCT01165697N/AUpdated Jan 13, 2017
Sponsor: Ohio State University
Fabry Disease
United States
A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal CancerCompleted
NCT02694718Phase 2Updated Jan 11, 2017
Sponsor: Hoffmann-La Roche
Rectal Cancer
Switzerland
The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 DiabetesCompleted
NCT02269098NAUpdated Jan 9, 2017
Sponsor: Medstar Health Research Institute
Diabetes Mellitus, Type 2 · Medication Adherence · HYPERGLYCEMIA
United States
Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic PatientsCompleted
NCT01768559Phase 3Updated Jan 4, 2017
Sponsor: Sanofi
Type 2 Diabetes
United States, Canada, Chile, Czechia, Estonia +13 more

Previous page Next page